ISTANBUL: August 26, 2016. Turkish Cargo has been awarded an IATA CEIV (Center of Excellence for Independent Validators) Pharma certificate for its Istanbul hub.
Turkey joins other airports including Brussels, Miami, Singapore and Zurich as IATA-recognized independent validators.
The airline says the recognition follows it successfully meeting the requirements of the international GDP guides (EU and WHO), IATA PCR (Perishable Cargo Regulations) Section 17 and TCR (Temperature Control Regulations), and targeting excellence in air cargo transportation and cargo handling services.
IATA says air cargo's share of the global pharma transport declined from 17 percent in 2000 to 11 percent by 2013 due to a lack of compliance, standardization, accountability and transparency. As a result it created a CEIV for pharma logistics to meet the growing requirements of shippers and manufacturers.
According to the Cool Chain Association, The total value of the pharmaceutical market is estimated at US$1.6 trillion by 2020 with India expected to be the largest pharma manufacturer in the world in less than 15 years. Another source says global pharma sales reached US$1 trillion in 2014 and expects the number to rise to US$1.3 trillion by 2018.
As the pharma market continues to grow, Turkish Cargo says while it is trying to increase market share, its first priority is the concerns of manufacturers and their focus on the importance of human health.
With this in mind, the Turkish Cargo terminal at Ataturk airport, Istanbul has 3,000 sq.mt. of specialized storage covering four different temperature ranges from -20 °C to +25 °C with healthcare products occupying a dedicated area of over 1,00 sq.mt.
In addition to thermal blankets and active container services to help customers, the airline says it is planning to introduce a temperature-controlled dolly service to protect critical shipments from extreme heat or cold during handling.